Similar articles

• [Clinico-experimental data on the efficacy of viloxazine in depressive states].

  Pirozynski T, Chiriţă V, Mungiu OC, Luchian M, Cosmovici N. Pirozynski T, et al. Rev Med Chir Soc Med Nat Iasi. 1988 Jan-Mar;92(1):49-52. Rev Med Chir Soc Med Nat Iasi. 1988. PMID: 3393762 Romanian. No abstract available.
• Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.

  Sebjanic V, Grombein S. Sebjanic V, et al. Adv Biochem Psychopharmacol. 1982;32:113-20. Adv Biochem Psychopharmacol. 1982. PMID: 7046360 Clinical Trial.
• A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.

  Tosca P, Zerbi F, Romani A, Molini G, Cairoli S, Montagna M, Gabba A, Groppi A. Tosca P, et al. Int J Clin Pharmacol Ther Toxicol. 1985 May;23(5):270-3. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 4008117
• Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

  Pinder RM, Brogden RN, Speight TM, Avery GS. Pinder RM, et al. Drugs. 1977 Jun;13(6):401-21. doi: 10.2165/00003495-197713060-00001. Drugs. 1977. PMID: 324751 Review. No abstract available.
• Update of antidepressants: lofepramine, amoxapine and viloxazine.

  [No authors listed] [No authors listed] Drug Ther Bull. 1990 Oct 15;28(21):82-4. Drug Ther Bull. 1990. PMID: 2131229 Review. No abstract available.